Citadel Advisors Portfolio holdings
Citadel Advisors, founded in 1990 by Kenneth C. Griffin as Citadel LLC and headquartered in Chicago, Illinois, is one of the world’s most prominent hedge funds, managing tens of billions in assets through sophisticated quantitative trading strategies. The firm excels in market-making and high-frequency trading across asset classes like equities, fixed income, options, and commodities, leveraging cutting-edge technology and data analysis to generate returns. Citadel operates two main arms: its hedge fund business, which serves institutional and high-net-worth investors, and Citadel Securities, a leading market maker that facilitates a significant portion of U.S. equity and options trades. Known for its secretive, high-performance culture, Citadel has grown into a financial titan under Griffin’s leadership, influencing global markets with its scale and innovation.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$2.49B |
| 2 |
NVIDIA
NVDA
|
+$2.19B |
| 3 |
State Street SPDR Dow Jones Industrial Average ETF Trust
DIA
|
+$1.94B |
| 4 |
TSMC
TSM
|
+$728M |
| 5 |
UnitedHealth
UNH
|
+$705M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Meta Platforms (Facebook)
META
|
+$775M |
| 2 |
AbbVie
ABBV
|
+$540M |
| 3 |
Delta Air Lines
DAL
|
+$434M |
| 4 |
Eli Lilly
LLY
|
+$433M |
| 5 |
DexCom
DXCM
|
+$433M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 4.89% |
| 2 | Healthcare | 2.92% |
| 3 | Financials | 2.71% |
| 4 | Consumer Discretionary | 2.52% |
| 5 | Industrials | 2.2% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
OKUR
8351
OnKure Therapeutics
OKUR
$154M
| $647K | ﹤0.01% |
223,125
-793,488
| -78% | -$2.38M |
|
8352
CALL
Euronet Worldwide
EEFT
$2.72B
| $647K | ﹤0.01% |
8,500
-2,200
| -21% | -$172K |
|
8353
CALL
VEON
VEON
$3.62B
| $647K | ﹤0.01% |
12,300
-12,100
| -50% | -$613K |
|
8354
Invesco Dorsey Wright Consumer Staples Momentum ETF
PSL
$84.8M
| $646K | ﹤0.01% |
+6,432
| New | +$667K |
|
8355
Hartford US Quality Growth ETF
HQGO
$49.2M
| $646K | ﹤0.01% |
10,748
+1,128
| +12% | +$67.4K |
|
8356
PUT
iShares US Broker-Dealers & Securities Exchanges ETF
IAI
$1.36B
| $646K | ﹤0.01% |
3,600
+2,100
| +140% | +$369K |
|
8357
EverQuote
EVER
$892M
| $645K | ﹤0.01% |
23,899
-11,576
| -33% | -$281K |
|
8358
VanEck Intermediate Muni ETF
ITM
$2.14B
| $645K | ﹤0.01% |
13,681
-11,570
| -46% | -$544K |
|
|
MFA
8359
PUT
MFA Financial
MFA
$926M
| $645K | ﹤0.01% |
69,300
-13,900
| -17% | -$129K |
|
8360
CALL
Nurix Therapeutics
NRIX
$2.41B
| $645K | ﹤0.01% |
34,000
+4,800
| +16% | +$69K |
|
|
CCD
8361
Calamos Dynamic Convertible & Income Fund
CCD
$707M
| $645K | ﹤0.01% |
30,972
+6,532
| +27% | +$140K |
|
|
CAI
8362
PUT
Caris Life Sciences
CAI
$4.43B
| $645K | ﹤0.01% |
23,900
+10,400
| +77% | +$293K |
|
8363
CALL
ACV Auctions
ACVA
$1.31B
| $645K | ﹤0.01% |
80,400
-34,500
| -30% | -$279K |
|
|
CRESY
8364
PUT
Cresud
CRESY
$795M
| $644K | ﹤0.01% |
51,000
+20,040
| +65% | +$222K |
|
8365
PUT
iShares Russell Mid-Cap Growth ETF
IWP
$19.8B
| $644K | ﹤0.01% |
4,700
-13,800
| -75% | -$1.93M |
|
8366
CALL
Red Violet
RDVT
$979M
| $644K | ﹤0.01% |
+11,300
| New | +$613K |
|
8367
CALL
Malibu Boats
MBUU
$541M
| $643K | ﹤0.01% |
22,800
-29,200
| -56% | -$847K |
|
8368
CALL
News Corp Class A
NWSA
$14.9B
| $643K | ﹤0.01% |
24,600
+12,200
| +98% | +$320K |
|
8369
PUT
GraniteShares 2x Long AMZN Daily ETF
AMZZ
$52M
| $642K | ﹤0.01% |
20,400
-10,300
| -34% | -$325K |
|
|
BKCG
8370
BNY Mellon Concentrated Growth ETF
BKCG
$121M
| $642K | ﹤0.01% |
+17,626
| New | +$634K |
|
8371
PUT
Ingersoll Rand
IR
$32.6B
| $642K | ﹤0.01% |
8,100
+1,800
| +29% | +$142K |
|
|
UPSX
8372
Tradr 2X Long UPST Daily ETF
UPSX
$18.9M
| $641K | ﹤0.01% |
+12,947
| New | +$779K |
|
8373
Riley Exploration Permian
REPX
$744M
| $641K | ﹤0.01% |
+24,269
| New | +$645K |
|
8374
PUT
East-West Bancorp
EWBC
$17.9B
| $641K | ﹤0.01% |
5,700
-13,000
| -70% | -$1.38M |
|
8375
Playboy Inc
PLBY
$128M
| $640K | ﹤0.01% |
340,678
+52,476
| +18% | +$85.7K |
|
Similar funds
Citadel Advisors's Q4 2025 Portfolio in Review
As of Q4 2025, Citadel Advisors held 14,701 positions worth $666B, up 1.3% from $657B the previous quarter. Its ten largest holdings account for 23% of the portfolio.
Citadel Advisors's Q4 2025 filing shows 2,078 new, 5,000 increased, 5,363 reduced and 2,191 closed positions. Its largest new stake was Medline Inc: 6,006,339 shares worth $252M. The largest sale was Meta Platforms (Facebook), an estimated $775M.
By sector, the portfolio is most concentrated in Technology at 4.9% of assets, up from 3.8% a quarter earlier, followed by Healthcare and Financials.
- Citadel Advisors's largest Q4 2025 buy was Medline Inc: 6,006,339 shares worth $252M.
- Citadel Advisors added most to Amazon in Q4 2025, an estimated $2.49B increase.
- Citadel Advisors's biggest Q4 2025 reduction was Meta Platforms (Facebook), cutting an estimated $775M.
- Citadel Advisors fully exited WEX in Q4 2025, selling an estimated $131M.
- Citadel Advisors's ten largest holdings make up 23% of its $666B portfolio in Q4 2025.
- Citadel Advisors opened 2,078 new positions and closed 2,191 in Q4 2025.
- Citadel Advisors's portfolio value rose 1.3% quarter-over-quarter to $666B.
Based on Citadel Advisors's 13F filing for Q4 2025, filed 17 Feb 2026.